human acute myeloid leukemia cell lines (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
human acute myeloid leukemia cell lines
Human Acute Myeloid Leukemia Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 6583 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+acute+myeloid+leukemia+cell+lines/HL-60/pm41980559-63-0-8
Average 99 stars, based on 6583 article reviews
Human Acute Myeloid Leukemia Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 6583 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+acute+myeloid+leukemia+cell+lines/HL-60/pm41980559-63-0-8
Average 99 stars, based on 6583 article reviews
human acute myeloid leukemia cell lines - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
other:Article Title: The Pharmacological Inhibition of ERK5 Enhances Apoptosis in Acute Myeloid Leukemia Cells Article Snippet: Human acute myeloid leukemia cell lines, Kasumi-1, HL-60 and Mutagenesis:Article Title: Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) FLT3 inhibitors Article Snippet: .. Materials and Methods Cell Lines and Primaries MV4-11 and MOLM-13 are human acute myeloid leukemia cell lines that carry a Atomic Absorption Spectroscopy:Article Title: Targeting BCL-2 and PI3K signaling pathways enhances cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cells. Article Snippet: Gemtuzumab ozogamicin (GO) is a humanized IgG4 anti-CD33 monoclonal antibody conjugated to the cytotoxic derivative of calicheamicin.. GO was the first antibody-drug conjugate (ADC) approved for the treatment of patients with CD33 acute myeloid leukemia (AML).. Although GO exhibits cytotoxic activity against AML cells, its effectiveness may be limited by resistance mechanisms, highlighting the need to develop strategies that increase cell sensitivity to this ADC. |